NIT
TWST icon

NumerixS Investment Technologies’s Twist Bioscience TWST Stock Holding History

NumerixS Investment Technologies’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,388
Closed -$108K – 795
2020
Q2 		$108K Sell
2,388
-703
-23% -$25.2K 0.03% 570
2020
Q1 		$95K Sell
3,091
-1,709
-36% -$45.9K 0.05% 438
2019
Q4 		$101K Buy
4,800
+3,300
+220% +$77.2K 0.02% 673
2019
Q3 		$36K Buy
+1,500
New +$43.6K 0.01% 796

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NumerixS Investment Technologies's TWST Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Twist Bioscience (TWST) in Q3 2020, closing a stake of 2,388 shares — an estimated $108K sold.

NumerixS Investment Technologies first reported a position in TWST in Q3 2019 and held it in 4 quarters. The position peaked at $108K in Q2 2020. 193 funds tracked by Wall St. Rank hold TWST as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Twist Bioscience position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 2,388 Twist Bioscience shares in Q3 2020, an estimated $108K.
  • NumerixS Investment Technologies first reported a position in Twist Bioscience in Q3 2019 and held it in 4 quarters.
  • NumerixS Investment Technologies's Twist Bioscience position peaked at $108K in Q2 2020.
  • 193 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.